Fasting-induced reduction in locomotor activity and reduced response of orexin neurons in carnitine-deficient mice

Neuroscience Research

Volumn 55, Issue 1, 2006, Pages 78-86

  Yoshida, Goichiro ^a,b   Li, Meng Xian ^a   Horiuchi, Masahisa ^a   Nakagawa, Shiro ^a   Sakata, Mie ^c   Kuchiiwa, Satoshi ^a   Kuchiiwa, Toshiko ^a   Jalil, Md Abdul ^a   Begum, Laila ^a   Lu, Yao Bang ^a   Iijima, Mikio ^a   Hanada, Takeshi ^d   Nakazato, Masamitsu ^d   Huang, Zhi Li ^e   Eguchi, Naomi ^c,e   Kobayashi, Keiko ^a   Saheki, Takeyori ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF FITNESS AND SPORTS IN KANOYA   (Japan)

^c WASEDA UNIVERSITY   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

^e OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Body core temperature; Carnitine; Fasting; Fatty acid oxidation; Juvenile visceral steatosis (jvs); Locomotor activity; Orexin; Sleep

Indexed keywords

CARNITINE; DOPAMINE; MODAFINIL; OREXIN; OREXIN A; PROTEIN C FOS; SUCROSE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CARNITINE DEFICIENCY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DARKNESS; DIET RESTRICTION; ENERGY RESOURCE; FEMALE; HYPOTHALAMUS; LOCOMOTION; MALE; MOUSE; NERVE CELL; NONHUMAN; NONREM SLEEP; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SLEEP; STEATOSIS; WAKEFULNESS;

EID: 33646007677     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.02.003     Document Type: Article

References (46)

1. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-451
2. Estabrooke I.V., McCarthy M.T., Ko E., Chou T.C., Chemelli R.M., Yanagisawa M., Saper C.B., and Scammell T.E. Fos expression in orexin neurons varies with behavioral state. J. Neurosci. 21 (2001) 1656-1662
3. Fish R.E. Pharmacology of injectable anesthetics. In: Kohn D.F., Wixson S.K., White W.J., and Benson G.J. (Eds). Anesthesia and Analgesia in Labolatory Animals (1997), Academic Press, New York 1-27
4. Fujiki N., Yoshida Y., Ripley B., Honda K., Mignot E., and Nishino S. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 h and in response to food deprivation. NeuroReport 12 (2001) 993-997
5. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., and Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30 (2001) 345-354
6. Horiuchi M., Kobayashi K., Tomomura M., Kuwajima M., Imamura Y., Koizumi T., Nikaido H., Hayakawa J., and Saheki T. Carnitine administration to juvenile visceral steatosis mice corrects the suppressed expression of urea cycle enzymes by normalizing their transcription. J. Biol. Chem. 267 (1992) 5032-5035
7. Horiuchi M., Yoshida H., Kobayashi K., Kuriwaki K., Yoshimine K., Tomomura M., Koizumi T., Nikaido H., Hayakawa J., Kuwajima M., and Saheki T. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett. 326 (1993) 267-271
8. Horiuchi M., Kobayashi K., Yamaguchi S., Shimizu N., Koizumi T., Nikaido H., Hayakawa J., Kuwajima M., and Saheki T. Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system. Biochim. Biophys. Acta 1226 (1994) 25-30
9. Horiuchi M., Kobayashi K., Asaka N., and Saheki T. Secondary abnormality of carnitine biosynthesis results from carnitine reabsorptional system defect in juvenile visceral steatosis mice. Biochim. Biophys. Acta 1362 (1997) 263-268
10. Horvath T.L., and Gao X.B. Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia. Cell Metab. 1 (2005) 279-286
11. Huang Z.L., Qu W.M., Li W.D., Mochizuki T., Eguchi N., Watanabe T., Urade Y., and Hayaishi O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9965-9970
12. Imamura Y., Saheki T., Arakawa H., Noda T., Koizumi T., Nikaido H., and Hayakawa J. Urea cycle disorder in C3H-H-2 degree mice with juvenile steatosis of viscera. FEBS Lett. 260 (1990) 119-121
13. Irifune M., Shimizu T., Nomoto M., and Fukuda T. Involvement of N-methyl-d-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Pharmacol. Biochem. Behav. 51 (1995) 291-296
14. Jalil Md.A., Horiuchi M., Wakamatsu M., Li M.X., Begum L., Suzuki K., Kobayashi K., Oka T., and Saheki T. Attenuation of cardiac hypertrophy in carnitine-deficient juvenile visceral steatosis (JVS) mice achieved by lowering dietary lipid. J. Biochem. (Tokyo) 139 (2006) 263-270
15. Kazi J.A., Mori S., Gao H.Z., Uehara F., and Nakagawa S. Effect of enucleation on the expression of c-Fos protein in the supraoptic nucleus of the Japanese monkey (Macaca fuscata). Brain Res. 952 (2002) 331-334
16. Koizumi T., Nikaido H., Hayakawa J., Nonomura A., and Yoneda T. Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2(0) strain of mouse with similarities to Reye's syndrome. Lab. Anim. 22 (1988) 83-87
17. Kotz C.M., Teske J.A., Levine J.A., and Wang C. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul. Pept. 104 (2002) 27-32
18. Kubota Y., Ito C., Sakurai E., Watanabe T., and Ohtsu H. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. J. Neurochem. 83 (2002) 837-845
19. Kuwajima M., Kono N., Horiuchi M., Imamura Y., Ono A., Inui Y., Kawata S., Koizumi T., Hayakawa J., Saheki T., and Tarui S. Animal model of systemic carnitine deficiency: analysis in C3H-H-2 degrees strain of mouse associated with juvenile visceral steatosis. Biochem. Biophys. Res. Commun. 174 (1991) 1090-1094
20. Li M.X., Kobayashi K., Horiuchi M., Jalil A., Yoshida G., and Saheki T. Hyperammonemia in carnitine-deficient adult JVS mice used by starvation. Metab. Brain Dis. 17 (2002) 359-366
21. Li Y., Gao X.-B., Sakurai T., and van den Pol A.N. Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron-a potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36 (2002) 1169-1181
22. Lu K., Nishimori H., Nakamura Y., Shima K., and Kuwajima M. A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse. Biochem. Biophys. Res. Commun. 252 (1998) 590-594
23. Lubkin M., and Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochem. Biophys. Res. Commun. 253 (1998) 241-245
24. Maric D., Millward J.M., Ballok D.A., Szechtman H., Denburg J.A., Barker J.L., and Sakic B. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice. Brain Res. 920 (2001) 183-193
25. Mieda M., Williams S.C., Sinton C.M., Richardson J.A., Sakurai T., and Yanagisawa M. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J. Neurosci. 24 (2004) 10493-10501
26. Mochizuki T., Crocker A., McCormack S., Yanagisawa M., Sakurai T., and Scammell T.E. Behavioral state instability in orexin knock-out mice. J. Neurosci. 24 (2004) 6291-6300
27. Nakajima T., Horiuchi M., Yamanaka H., Kizaki Z., Inoue F., Kodo N., Kinugasa A., Saheki T., and Sawada T. The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency. Pediatr. Res. 42 (1997) 108-113
28. Nakamura T., Uramura K., Nambu T., Yada T., Goto K., Yanagisawa M., and Sakurai T. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 873 (2000) 181-187
29. Nezu J., Tamai I., Oku A., Ohashi R., Yabuuchi H., Hashimoto N., Nikaido H., Sai Y., Koizumi A., Shoji Y., Takada G., Matsuishi T., Yoshino M., Kato H., Ohura T., Tsujimoto G., Hayakawa J., Shimane M., and Tsuji A. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat. Genet. 21 (1999) 91-94
30. Parmentier R., Ohtsu H., Djebbara-Hannas Z., Valatx J.L., Watanabe T., and Lin J.S. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J. Neurosci. 22 (2002) 7695-7711
31. Pollitt R.J. Disorders of mitochondrial long-chain fatty acid oxidation. J. Inherit. Metab. Dis. 18 (1995) 473-490
32. Qi S.L., Araki K., Miyazaki J., and Yamamura K. Rapid identification of transgenic mice with PCR amplification of DNA from ear punching. Meth. Mol. Cell Biol. 2 (1991) 119-122
33. Saheki T., Li M.X., and Kobayashi K. Antagonizing effect of AP-1 on glucocorticoid induction of urea cycle enzymes: a study of hyperammonemia in carnitine-deficient, juvenile visceral steatosis mice. Mol. Genet. Metab. 71 (2000) 545-551
34. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 573-585
35. Saudubray J.M., Martin D., de Lonlay P., Touati G., Poggi-Travert F., Bonnet D., Jouvet P., Boutron M., Slama A., Vianey-Saban C., Bonnefont J.P., Rabier D., Kamoun P., and Brivet M. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J. Inherit. Metab. Dis. 22 (1999) 488-502
36. Stricker-Krongrad A., Richy S., and Beck B. Orexins/hypocretins in the ob/ob mouse: hypothalamic gene expression, peptide content and metabolic effects. Regul. Pept. 104 (2002) 11-20
37. Sutcliffe J.G., and de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J. Neurosci. Res. 62 (2000) 161-168
38. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., Sai Y., and Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273 (1998) 20378-20382
39. Tanaka M., Nakamura F., Mizokawa S., Matsumura A., Matsumura K., and Watanabe Y. Role of acetyl-l-carnitine in the brain: revealed by bioradiography. Biochem. Biophys. Res. Commun. 306 (2003) 1064-1069
40. Thorpe A.J., and Kotz C.M. Orexin A in the nucleus accumbens stimulates feeding and locomotor activity. Brain Res. 1050 (2005) 156-162
41. Tobler I., Deboer T., and Fischer M. Sleep and sleepregulation in normal and prion protein-deficient mice. J. Neurosci. 17 (1997) 1869-1879
42. Tomomura M., Tomomura A., Musa D.A., Horiuchi M., Takiguchi M., Mori M., and Saheki T. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood. J. Biochem. (Tokyo) 121 (1997) 172-177
43. Toth E., Harsing Jr. L.G., Sershen H., Ramacci M.T., and Lajtha A. Effect of acetyl-l-carnitine on extracellular amino acid levels in vivo in rat brain regions. Neurochem. Res. 18 (1993) 573-578
44. Willie J.T., Chemelli R.M., Sinton C.M., Tokita S., Williams S.C., Kisanuki Y.Y., Marcus J.N., Lee C., Elmquist J.K., Kohlmeier K.A., Leonard C.S., Richardson J.A., Hammer R.E., and Yanagisawa M. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 38 (2003) 715-730
45. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., and Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. J. Neurosci. 21 (2001) 1787-1794
46. Yoshimichi G., Yoshimatsu H., Masaki T., and Sakata T. Orexin-A regulates body temperature in coordination with arousal status. Exp. Biol. Med. (Maywood) 226 (2001) 468-476